Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Verrica Pharmaceuticals Inc. VRCA

Full chart Compare
Set alert

Price alert · VRCA

All alert types
3.38 USD +0.09 (+2.74%)

Nov 4, 2026, 12:08 PM EST

3.36 Day range 3.42
3.20 52-week range 9.82
YTD
-59.33%
1 year
+3.05%

Financial health

Altman Z-Score

-13.78 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 1

Valuation

P/E -4.9×
FY 2016: -235×FY 2017: -46.1×FY 2018: -9.8×FY 2019: -14.0×FY 2020: -6.7×FY 2021: -7.1×FY 2022: -3.8×FY 2023: -5.0×FY 2024: -0.5×FY 2025: -4.9×
FY 2016 5y median -4.9× FY 2025
P/S 2.5×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 20.6×FY 2022: 10.4×FY 2023: 64.8×FY 2024: 4.8×FY 2025: 2.5×
FY 2016 5y median 10.4× FY 2025
P/B 3.6×
FY 2016: -169×FY 2017: -63.9×FY 2018: 2.3×FY 2019: 6.1×FY 2020: 8.7×FY 2021: 7.6×FY 2022: 2.3×FY 2023: 16.8×FY 2024: -3.7×FY 2025: 3.6×
FY 2016 5y median 3.6× FY 2025
P/FCF -5.0×
FY 2016: -279×FY 2017: -98.1×FY 2018: -10.9×FY 2019: -14.1×FY 2020: -9.1×FY 2021: -8.7×FY 2022: -5.0×FY 2023: -8.5×FY 2024: -0.6×FY 2025: -5.0×
FY 2016 5y median -5.0× FY 2025
EV/EBITDA -6.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -9.3×FY 2019: -13.8×FY 2020: -8.0×FY 2021: -9.1×FY 2022: -2.8×FY 2023: -4.9×FY 2024: -0.5×FY 2025: -6.4×
FY 2016 5y median -4.9× FY 2025
EV/Sales 1.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 22.9×FY 2022: 6.8×FY 2023: 60.1×FY 2024: 4.7×FY 2025: 1.7×
FY 2016 5y median 6.8× FY 2025
FCF Yield -19.9%
FY 2016: -0.4%FY 2017: -1.0%FY 2018: -9.2%FY 2019: -7.1%FY 2020: -11.0%FY 2021: -11.5%FY 2022: -20.2%FY 2023: -11.7%FY 2024: -168.1%FY 2025: -19.9%
FY 2016 5y median -19.9% FY 2025

Profitability

Gross Margin 90.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 96.1%FY 2022: 92.0%FY 2023: 85.4%FY 2024: 63.8%FY 2025: 90.3%
FY 2016 5y median 90.3% FY 2025
Operating Margin -33.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -257.6%FY 2022: -235.8%FY 2023: -1283.4%FY 2024: -871.3%FY 2025: -33.6%
FY 2016 5y median -257.6% FY 2025
Net Margin -50.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -292.3%FY 2022: -271.1%FY 2023: -1307.5%FY 2024: -1012.1%FY 2025: -50.3%
FY 2016 5y median -292.3% FY 2025
ROE -72.3%
FY 2016: 71.8%FY 2017: 63.3%FY 2018: -23.1%FY 2019: -43.4%FY 2020: -137.9%FY 2021: -107.6%FY 2022: -61.2%FY 2023: -339.0%FY 2024: 776.7%FY 2025: -72.3%
FY 2016 5y median -72.3% FY 2025
ROIC -38.0%
FY 2016: -1530.4%FY 2017: -52.6%FY 2018: -24.5%FY 2019: -46.1%FY 2020: -57.2%FY 2021: -40.7%FY 2022: -51.2%FY 2023: -100.7%FY 2024: -170.2%FY 2025: -38.0%
FY 2016 5y median -51.2% FY 2025
ROA -37.9%
FY 2016: -351.7%FY 2017: -49.1%FY 2018: -22.5%FY 2019: -41.2%FY 2020: -61.4%FY 2021: -43.8%FY 2022: -54.8%FY 2023: -82.1%FY 2024: -141.5%FY 2025: -37.9%
FY 2016 5y median -54.8% FY 2025

Growth (YoY)

Revenue 370.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -24.7%FY 2023: -43.3%FY 2024: 47.7%FY 2025: 370.2%
FY 2016 FY 2025
Operating Income 81.9%
FY 2016: 0.0%FY 2017: -133.0%FY 2018: -390.9%FY 2019: -37.5%FY 2020: -33.6%FY 2021: 23.1%FY 2022: 31.1%FY 2023: -208.8%FY 2024: -0.2%FY 2025: 81.9%
FY 2016 FY 2025
EPS (diluted) 88.6%
FY 2016: 0.0%FY 2017: -410.1%FY 2018: -118.8%FY 2019: -36.3%FY 2020: -50.8%FY 2021: 24.1%FY 2022: 44.7%FY 2023: -106.1%FY 2024: 0.0%FY 2025: 88.6%
FY 2016 FY 2025
Free Cash Flow 71.1%
FY 2016: 0.0%FY 2017: -184.5%FY 2018: -306.9%FY 2019: -50.6%FY 2020: -12.8%FY 2021: 10.1%FY 2022: 33.4%FY 2023: -105.5%FY 2024: -56.5%FY 2025: 71.1%
FY 2016 FY 2025

Financial Health

Current Ratio 2.6×
FY 2016: 1.3×FY 2017: 14.7×FY 2018: 36.8×FY 2019: 19.4×FY 2020: 1.7×FY 2021: 1.6×FY 2022: 11.3×FY 2023: 4.6×FY 2024: 1.8×FY 2025: 2.6×
FY 2016 5y median 2.6× FY 2025
Quick Ratio 2.5×
FY 2016: 1.3×FY 2017: 14.7×FY 2018: 36.8×FY 2019: 19.4×FY 2020: 1.7×FY 2021: 1.6×FY 2022: 11.3×FY 2023: 4.5×FY 2024: 1.7×FY 2025: 2.5×
FY 2016 5y median 2.5× FY 2025
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 1.1×FY 2021: 1.3×FY 2022: 0.0×FY 2023: 2.3×FY 2024: -4.7×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 3.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.5×FY 2019: 0.3×FY 2020: -0.7×FY 2021: -0.9×FY 2022: 1.5×FY 2023: 0.4×FY 2024: 0.0×FY 2025: 3.0×
FY 2016 5y median 0.4× FY 2025
Interest Coverage -1.5×
FY 2016: 0.0×FY 2017: -2229×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -13.2×FY 2021: -7.2×FY 2022: -9.8×FY 2023: -16.6×FY 2024: -7.0×FY 2025: -1.5×
FY 2016 5y median -7.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31